Join us from January 23-25 at the mRNA-Based Therapeutics Summit Europe 2024 - in Berlin - for an introduction by our founder, unraveling the immense potential of leveraging a commercially validated "ribosome platform".
IMMAGINA Biotechnology, the Ribosome company, released today the AHARIBO Translatome RNAseq system, the first commercially available complete system to analyse gene expression at the ribosome level (Translatome).